Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RALOXIFENE Cause Bone density decreased? 228 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 228 reports of Bone density decreased have been filed in association with RALOXIFENE (Raloxifene Hydrochloride). This represents 5.5% of all adverse event reports for RALOXIFENE.

228
Reports of Bone density decreased with RALOXIFENE
5.5%
of all RALOXIFENE reports
0
Deaths
4
Hospitalizations

How Dangerous Is Bone density decreased From RALOXIFENE?

Of the 228 reports, 4 (1.8%) required hospitalization, and 1 (0.4%) were considered life-threatening.

Is Bone density decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RALOXIFENE. However, 228 reports have been filed with the FAERS database.

What Other Side Effects Does RALOXIFENE Cause?

Body height decreased (386) Muscle spasms (295) Pain in extremity (286) Pain (252) Hot flush (204) Arthralgia (202) Drug ineffective (184) Arthritis (142) Dizziness (125) Pulmonary embolism (119)

What Other Drugs Cause Bone density decreased?

EMTRICITABINE\TENOFOVIR DISOPROXIL (16,315) TENOFOVIR DISOPROXIL (10,586) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (9,547) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (4,529) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (3,497) TERIPARATIDE (1,178) DENOSUMAB (968) METHOTREXATE (599) ADALIMUMAB (584) TOCILIZUMAB (573)

Which RALOXIFENE Alternatives Have Lower Bone density decreased Risk?

RALOXIFENE vs RALTEGRAVIR RALOXIFENE vs RALTITREXED RALOXIFENE vs RAMELTEON RALOXIFENE vs RAMIPRIL RALOXIFENE vs RAMUCIRUMAB

Related Pages

RALOXIFENE Full Profile All Bone density decreased Reports All Drugs Causing Bone density decreased RALOXIFENE Demographics